The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

書誌詳細
主要な著者:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
フォーマット:	Journal article
言語:	English
出版事項:	2009

類似資料

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
著者:: Edmond Auzenne, 等
出版事項: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
著者:: Wachsberger, P, 等
出版事項: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
著者:: Lavinia Morosi, 等
出版事項: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
著者:: Choi, S, 等
出版事項: (2008)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
著者:: Martina Vescio, 等
出版事項: (2023-07-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
著者:: Demuytere J, 等
出版事項: (2024-01-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
著者:: Hideki Iwamoto, 等
出版事項: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
著者:: Cervellini, I, 等
出版事項: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
著者:: Tai, J, 等
出版事項: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
著者:: Tai, J, 等
出版事項: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
著者:: Nils Degrauwe, 等
出版事項: (2012-06-01)

Selective use of vandetanib in the treatment of thyroid cancer
著者:: Fallahi P, 等
出版事項: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
著者:: Kabir, Md Zahirul, 等
出版事項: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
著者:: Abdul Qadir, MPhil, 等
出版事項: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
著者:: Jade Cury-Martins, 等
出版事項: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
著者:: Roberta Affatato, 等
出版事項: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
著者:: Zhou, J, 等
出版事項: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
著者:: Alferez, D, 等
出版事項: (2010)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
著者:: Heymach, J, 等
出版事項: (2008)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
著者:: Francesca Ricci, 等
出版事項: (2017-05-01)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
著者:: Siemann, D, 等
出版事項: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
著者:: Yuxin Shen, 等
出版事項: (2025-03-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
著者:: Ai Matsui, 等
出版事項: (2022-01-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
著者:: Paola De Feudis, 等
出版事項: (2000-05-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
著者:: Joseph J. Caumanns, 等
出版事項: (2025-02-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
著者:: T. Laragione, 等
出版事項: (2005-01-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
著者:: Robert J G Cardnell, 等
出版事項: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
著者:: Fallahi P, 等
出版事項: (2019-08-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
著者:: Busra Demirbag Gul, 等
出版事項: (2022-02-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
著者:: Carlos M. Galmarini, 等
出版事項: (2014-01-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
著者:: E. A. Samishina, 等
出版事項: (2019-06-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
著者:: Alberto Zambelli, 等
出版事項: (2023-01-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
著者:: Hartwig Kosmehl, 等
出版事項: (2002-12-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
著者:: Jr, W, 等
出版事項: (2012)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
著者:: Pepe D, 等
出版事項: (2016-05-01)

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer
著者:: Meijia Yu, 等
出版事項: (2024-05-01)

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
著者:: Federica Guffanti, 等
出版事項: (2024-06-01)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
著者:: Kumar, K, 等
出版事項: (2013)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
著者:: Kumar, K, 等
出版事項: (2013)

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
著者:: Xiaoyue Zeng, 等
出版事項: (2024-05-01)